Under construction – not a live service
Sign in
Taking peopleNo phase

Long-term follow-up of two ablation approaches for persistent atrial fibrillation

Follows people with persistent atrial fibrillation after tailored or standard heart ablation.

Plain-language title generated from the registry record
Registry title: Long-Term Evaluation of TAILORED Vs Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Key facts

Where
Coburg and Munich, GermanySee the 2 sites

Where in Germany

  • Klinikum CoburgCoburg, GermanyNot yet recruiting
  • German Heart CenterMunich, GermanyNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Volta Medical
Trial code
NCT06825104
Record updated
13 March 2025
Original description
The TAILORED-LT study is conducted as an extension follow-up until 5 years of the initial TAILORED-AF study (NCT04702451), in order to demonstrate the long-term superiority in terms of freedom of atrial fibrillation (AF) of a tailored ablation strategy targeting areas of spatio-temporal dispersed electrograms in combination with pulmonary veins isolation (PVI) over an anatomical ablation strategy targeting PVI alone for the initial ablation procedure of persistent AF.Read full original descriptionShow less

Long-Term Evaluation of TAILORED Vs Anatomical Ablation Strategy for Persistent Atrial Fibrillation

The TAILORED-LT study is conducted as an extension follow-up until 5 years of the initial TAILORED-AF study (NCT04702451), in order to demonstrate the long-term superiority in terms of freedom of atrial fibrillation (AF) of a tailored ablation strategy targeting areas of spatio-temporal dispersed electrograms in combination with pulmonary veins isolation (PVI) over an anatomical ablation strategy targeting PVI alone for the initial ablation procedure of persistent AF.

Inclusion: Patient who participated in the Tailored AF study; Patient not withdrawn during the 12-month follow-up period post-index procedure in the Tailored AF study; Patient able and willing to provide written informed consent to participate in this extension Tailored-LT study.

Exclusion: Person deprived of liberty or under guardianship; Person unable to undergo a medical monitoring for geographical, social or psychological reasons.

ClinicalTrials.gov NCT06825104